FIELD: medical engineering. SUBSTANCE: method involves intranasally administering 0.1% solution of Semax curative preparation as instillations 2-4 drops 2-3 times a day during 7-14 days and applying endonasal electrophoresis with 8-10 drops placed on forked positive electrode once a day during 7- 10 days. EFFECT: improved vision function; stimulated regeneration processes. 3 cl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF OPTIC NERVE ATROPHY WITH OPTIC DISC DRUSEN | 2022 |
|
RU2788811C1 |
| METHOD OF TREATING OPTIC NERVE ATROPHY IN INFANTS | 2011 |
|
RU2458702C1 |
| METHOD OF TREATING PATIENTS WITH PARTIAL ATROPHY OF OPTIC NERVES | 1996 |
|
RU2124875C1 |
| METHOD OF TREATING DISEASES OF OPTIC NERVE AND RETINA | 2008 |
|
RU2373904C1 |
| METHOD FOR TREATMENT OF BILATERAL OPTIC NERVE EDEMA AFTER COVID-19 | 2022 |
|
RU2773135C1 |
| METHOD FOR ATROPHY OF OPTIC NERVE TREATMENT | 1991 |
|
RU2008859C1 |
| METHOD OF OPTICAL NEURITIS TREATMENT | 2009 |
|
RU2414900C1 |
| METHOD FOR PREDICTING AND RECONSTRUCTING VISUAL FUNCTIONS AT PARTIAL ATROPHY OF OPTIC NERVE IN CHILDREN | 2005 |
|
RU2295936C2 |
| METHOD OF TREATING VISUAL NERVE AND RETINAL DISEASES | 2010 |
|
RU2447864C1 |
| METHOD FOR OPTIC NERVE ATROPHY TREATMENT AFTER CRANIOCEREBRAL INJURY | 2017 |
|
RU2635485C1 |
